• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

CT reveals traits of drug-resistanttuberculosis

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 31 No 6
Volume 31
Issue 6

Micronodules, tree-in-bud appearance, consolidations, cavities, bronchiectasis, and lobular consolidations are frequent CT abnormalities of extensively drug-resistant tuberculosis.

Micronodules, tree-in-bud appearance, consolidations, cavities, bronchiectasis, and lobular consolidations are frequent CT abnormalities of extensively drug-resistant tuberculosis.

Researchers at the Seoul National Hospital in Korea made the discovery after a retrospective review of tests from 260 patients diagnosed with multidrug-resistant tuberculosis from 1994 to 2005. The researchers found that 47 patients had drug-resistant TB, while 213 had multidrug-resistant TB.

CT exams of 20 of the 47 drug-resistant and 85 of the 213 multidrug-resistant TB patients revealed micronodules and tree-inbud appearance in all of them. About 70% of patients showed lobular consolidations. Cavities and bronchiectasis were also conspicuous on CT.

Drug-resistant TB is a serious public health issue in many countries. Radiologists should consider the possibility of TB upon identifying signs, Lee said. He presented the study at the 2008 RSNA meeting.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.